Becton Dickinson & Co (BDX)
233.50
-1.74
(-0.74%)
USD |
NYSE |
Nov 04, 13:09
Becton Dickinson Enterprise Value: 82.01B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 82.01B |
| October 31, 2024 | 81.53B |
| October 30, 2024 | 82.40B |
| October 29, 2024 | 82.66B |
| October 28, 2024 | 83.07B |
| October 25, 2024 | 82.84B |
| October 24, 2024 | 82.98B |
| October 23, 2024 | 83.53B |
| October 22, 2024 | 83.30B |
| October 21, 2024 | 83.53B |
| October 18, 2024 | 84.47B |
| October 17, 2024 | 83.48B |
| October 16, 2024 | 83.45B |
| October 15, 2024 | 83.91B |
| October 14, 2024 | 83.39B |
| October 11, 2024 | 82.37B |
| October 10, 2024 | 82.09B |
| October 09, 2024 | 82.87B |
| October 08, 2024 | 82.57B |
| October 07, 2024 | 82.65B |
| October 04, 2024 | 82.87B |
| October 03, 2024 | 82.62B |
| October 02, 2024 | 83.31B |
| October 01, 2024 | 83.87B |
| September 30, 2024 | 83.70B |
| Date | Value |
|---|---|
| September 27, 2024 | 83.82B |
| September 26, 2024 | 82.59B |
| September 25, 2024 | 82.00B |
| September 24, 2024 | 82.50B |
| September 23, 2024 | 81.86B |
| September 20, 2024 | 81.50B |
| September 19, 2024 | 81.83B |
| September 18, 2024 | 80.95B |
| September 17, 2024 | 80.86B |
| September 16, 2024 | 81.66B |
| September 13, 2024 | 81.70B |
| September 12, 2024 | 82.08B |
| September 11, 2024 | 81.56B |
| September 10, 2024 | 82.14B |
| September 09, 2024 | 82.58B |
| September 06, 2024 | 81.26B |
| September 05, 2024 | 81.43B |
| September 04, 2024 | 82.33B |
| September 03, 2024 | 84.01B |
| August 30, 2024 | 84.08B |
| August 29, 2024 | 83.66B |
| August 28, 2024 | 83.07B |
| August 27, 2024 | 82.80B |
| August 26, 2024 | 82.31B |
| August 23, 2024 | 82.34B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
71.87B
Minimum
Mar 23 2020
98.12B
Maximum
Jul 27 2023
85.59B
Average
84.84B
Median
Jul 08 2021
Enterprise Value Benchmarks
| Abbott Laboratories | 213.13B |
| Boston Scientific Corp | 131.03B |
| Baxter International Inc | 29.17B |
| QuidelOrtho Corp | 5.086B |
| Edwards Lifesciences Corp | 39.36B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 487.00M |
| Revenue (Quarterly) | 4.99B |
| Total Expenses (Quarterly) | 4.276B |
| EPS Diluted (Quarterly) | 1.68 |
| Gross Profit Margin (Quarterly) | 46.23% |
| Profit Margin (Quarterly) | 9.76% |
| Earnings Yield | 2.08% |
| Operating Earnings Yield | 3.74% |
| Normalized Earnings Yield | 2.741 |